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Paracrystals of STAT proteins and their dissolution by SUMO: 
How reduced transcription factor solubility increases cytokine 
signaling
Mathias Droescher, Andreas Begitt, and Uwe Vinkemeier
The cell nucleus is a highly organized organelle. 
In the past decade, a multitude of nuclear substructures 
and their possible role in gene regulation were identified 
[1]. We are studying STAT transcription factors, which 
comprise a structurally and functionally conserved family 
of proteins with indispensable roles in cytokine signaling. 
Cytokine  binding  to  specific  membrane  receptors  first 
activates receptor-associated JAK tyrosine kinases, 
which activate STAT proteins by phosphorylating a single 
C-terminal tyrosine. The activated STATs possess DNA-
binding activity and evoke transcriptional responses to 
cytokines [2]. We discovered that activated STAT dimers 
can polymerize and assemble paracrystalline arrays in 
the nucleus of cytokine-stimulated cells [3]. Hepatocytes 
are an example, which harbor STAT3 paracrystals during 
systemic bacterial infection. Paracrystal formation is 
governed by the principle of self-organization [4] and 
necessitates a threshold concentration of the activated 
STAT [3]. STAT paracrystals are dynamic and reversible 
structures that form randomly and independently of 
specific  nuclear  components.  Although  paracrystal 
formation decreased the abundance of the soluble and 
hence transcriptionally active STAT, its transcriptional 
response was enhanced [3]. 
Paracrystal formation seems to be an inherent 
property of the STAT family, but STAT1 normally does 
not form these structures. We could show that this is 
due to the unique ability of STAT1 among the STATs 
to  conjugate  to  small  ubiquitin-like  modifier  (SUMO) 
[3]. SUMO conjugation can lead to the association of 
proteins,  e.g.  PML  bodies.  In  contrast,  sumoylation 
dissociated  STAT1  paracrystals.  SUMO  facilitated  the 
generation of a competitive polymerization inhibitor, 
namely semi-phosphorylated STAT1 dimers. These 
in turn competed with their fully phosphorylated 
counterparts and interfered with their polymerization into 
paracrystals. Importantly, the competition itself and hence 
the prevention of paracrystals was achieved entirely 
independent of SUMO’s continued presence [3]. 
STAT  paracrystal  dissolution  by  SUMO  thus 
constitutes a showcase example of how a disproportionately 
small SUMO-modified fraction determines the behavior 
of the entire pool of molecules, also known as the 
“SUMO  enigma”  [5]. We  propose  that  in  many  cases 
the solution to it entails the mutual exclusion of SUMO 
conjugation  and  another  protein  modification  -tyrosine 
phosphorylation in the case of STAT1 [3]. Thus, SUMO 
acts as a bulky obstacle to another modifying event, e.g. 
ubiquitination or proteolytic cleavage. In this way SUMO 
conjugation facilitates the generation of molecules that 
have different properties than those that have not been 
SUMO-modified.  Importantly,  these  molecules  can 
subsequently act as competitive inhibitors of protein 
interactions entirely independent of SUMO. We propose 
that  these  mechanisms  are  underlying  several  SUMO-
dependent protein regulatory events, one of which is 
control of protein polymerization and hence solubility.
We then explored the physiological consequences 
associated with paracrystal dissolution by a small SUMO-
modified  STAT1  fraction.  By  using  knock-in  mice 
expressing  exclusively  SUMO-free  STAT1  we  could 
show that paracrystals demonstrated a buffer property for 
activated STAT1, such that SUMO-mediated paracrystal 
dispersal profoundly accelerated the dephosphorylation 
of STAT1 [6]. Accordingly, the curtailed STAT1 activity 
in the nucleus resulted in diminished transcription 
of  IFNγ-responsive  genes.  Furthermore,  while  the 
already known negative regulators of STAT1 function 
in a feedback manner, sumoylation acts as a permanent 
attenuator of IFNγ signaling. This in turn protected cells 
from hyperresponsiveness towards this cytokine and its 
potentially self-destructive consequences [6].
In summary, we present STAT paracrystals as a 
model for the regulation of protein solubility by SUMO. 
We propose that the mechanisms underlying this 
phenomenon are of importance for understanding how 
SUMO generally regulates protein function. Paracrystals 
were identified as reservoirs for activated STATs which 
play a central role in the positive regulation of STAT-
signaling.  The  SUMO  conjugation  of  STAT1  may 
interfere with the polymerization of other STAT family 
members too, providing a structural basis for the cross-
regulation of multiple cytokine signaling pathways 
by  IFNγ.  Furthermore,  in  conjunction  with  its  great 
significance  for  interferon  signaling,  the  modulation 
of  STAT1  SUMO  conjugation  thus  becomes  feasible 
for pharmacological interventions with therapeutic 
potential  in  inflammatory  and  immune  disorders. Oncotarget 2011; 2:  527 - 528 528 www.impactjournals.com/oncotarget
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